Latest News

Publications

October 1, 2020

A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients

Madeleine Morrissette, Norman Pitt, Antonio González, Philip Strandwitz, Mariaelena Caboni, Alison W. Rebman, Rob Knight, Anthony D’Onofrio, John N. Aucott, Mark J. Soloski, Kim Lewis

March 2, 2020

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31

Venkata Raveendra Pothineni, Hari-Hara S. K. Potula, Aditya Ambati, Venkata Vamsee Aditya Mallajosyula, Brindha Sridharan, Mohammed Inayathullah, Mohamed Sohail Ahmed, and Jayakumar Rajadas

December 16, 2019

Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group

By Samuel Shor, Christine Green, Beatrice Szantyr, Steven Philips, Kenneth Liegner, Joseph Burrascano Jr., Robert Bransfield, Elizabeth L. Maloney

November 16, 2009

Ineffectiveness of tigecycline against persistent Borrelia burgdorferi

By Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft BJ

January 27, 1994

Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis

By Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC

09-01-2021

Register Now for LDA-Columbia Virtual Conf./New LDA Dr. Referral/Cohen TBD Recovery Center Launch/The State of Lyme Disease/Moderna Vs. Pfizer/Organ-Transplant-Derived Ehrlichiosis/B. Mayonii on Blood Smear/T Cell Exhaustion/COVID in Deer/TBDWG/ABEM

08-31-2021

NEW: LDA State-of-the-Art Doctor Referral Now Open!

08-27-2021

Launch of Columbia’s Cohen Center for Health and Recovery from Tick-Borne Diseases

08-23-2021

Moderna Vs. Pfizer: COVID-19 Vaccine Effectiveness

08-23-2021

Lyme Disease Association-Columbia Virtual Conference Register Now

08-23-2021

Prominent Researchers: The State of Lyme Disease: Progress & Challenges